Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.